Industry, innovation and social values
- PMID: 15726997
- PMCID: PMC7089058
- DOI: 10.1007/s11948-005-0053-9
Industry, innovation and social values
Abstract
Remaining important tasks in finding and developing new drugs and vaccines for HIV/AIDS, malaria, cancer and other diseases require continued industry research and development. Industry's research and development pipeline has produced drugs that have saved AIDS victims previously facing certain death, but still no cure nor vaccine is yet available. Experience with the process of research and development indicates that it requires more than a decade of development to produce a new drug with costs in the hundreds of millions of dollars. Intellectual property protection is critically important in assuring that drug development continues. Partnerships between industry and the public sector have increased access to new therapies in developing countries and promise to enhance access to both patented and generic medicines in the future.
References
-
- Commission on Macroeconomics and Health, Macroeconomics and health: Investing in health for economic development. CMH/WHO 2001, pp- 21–29.
-
- Brower J., Chalk P. (2003) The global threat of new and re-emerging infectious diseases: reconciling US national security and public health policy. Rand Science and Technology 2003.
-
- Joint United Nations Programme on HIV/AIDS (UNAIDS), AIDS Epidemic Update: December 2003. UNAIDS 2003.
-
- Reichert J.M., Milne Ch. P. (2000) Public good and private goods: the role of industry, academia, and government in drug discovery and development. Tufts Centre for the Study of Drug Development, 2000.
-
- Henderson R., Cockburn I. (1993) Measuring competence? Exploring Firm Effects in Pharmaeutical Research. Strategic Management Journal, No. 15.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical